BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2554 related articles for article (PubMed ID: 11782374)

  • 21. Evaluation of organoselenium compounds for potential chemopreventive properties in colon carcinogenesis.
    Reddy BS; Upadhyaya P; Simi B; Rao CV
    Anticancer Res; 1994; 14(6B):2509-14. PubMed ID: 7872674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combinatorial chemoprevention: efficacy of lovostatin and exisulind on the formation and progression of aberrant crypt foci.
    Kim KP; Whitehead C; Piazza G; Wargovich MJ
    Anticancer Res; 2004; 24(3a):1805-11. PubMed ID: 15274359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of colon carcinogenesis by bioactive compounds in grapefruit.
    Vanamala J; Leonardi T; Patil BS; Taddeo SS; Murphy ME; Pike LM; Chapkin RS; Lupton JR; Turner ND
    Carcinogenesis; 2006 Jun; 27(6):1257-65. PubMed ID: 16387741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate.
    Reddy BS; Rivenson A; Kulkarni N; Upadhyaya P; el-Bayoumy K
    Cancer Res; 1992 Oct; 52(20):5635-40. PubMed ID: 1394188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of azoxymethane and curcumin on transcriptional levels of cyclooxygenase-1 and -2 during initiation of colon carcinogenesis.
    Kwon Y; Magnuson BA
    Scand J Gastroenterol; 2007 Jan; 42(1):72-80. PubMed ID: 17190766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of azoxymethane-induced colon cancer development in rats by a cyclooxygenase-1 selective inhibitor, mofezolac.
    Niho N; Kitamura T; Takahashi M; Mutoh M; Sato H; Matsuura M; Sugimura T; Wakabayashi K
    Cancer Sci; 2006 Oct; 97(10):1011-4. PubMed ID: 16984374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis.
    Kawamori T; Uchiya N; Kitamura T; Ohuchida S; Yamamoto H; Maruyama T; Sugimura T; Wakabayashi K
    Anticancer Res; 2001; 21(6A):3865-9. PubMed ID: 11911260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats.
    Suzuki R; Yasui Y; Kohno H; Miyamoto S; Hosokawa M; Miyashita K; Tanaka T
    Oncol Rep; 2006 Nov; 16(5):989-96. PubMed ID: 17016582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemopreventive effects of a selective nitric oxide synthase inhibitor on carcinogen-induced rat esophageal tumorigenesis.
    Chen T; Nines RG; Peschke SM; Kresty LA; Stoner GD
    Cancer Res; 2004 May; 64(10):3714-7. PubMed ID: 15150132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats.
    Tanaka T; Kohno H; Shimada R; Kagami S; Yamaguchi F; Kataoka S; Ariga T; Murakami A; Koshimizu K; Ohigashi H
    Carcinogenesis; 2000 Jun; 21(6):1183-9. PubMed ID: 10837008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.
    Swamy MV; Patlolla JM; Steele VE; Kopelovich L; Reddy BS; Rao CV
    Cancer Res; 2006 Jul; 66(14):7370-7. PubMed ID: 16849589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats.
    Raju J; Bird RP
    Cancer Res; 2003 Oct; 63(20):6595-601. PubMed ID: 14583451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis.
    Tanaka T; Kojima T; Suzui M; Mori H
    Cancer Res; 1993 Sep; 53(17):3908-13. PubMed ID: 8358716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2.
    Takahashi M; Fukutake M; Yokota S; Ishida K; Wakabayashi K; Sugimura T
    J Cancer Res Clin Oncol; 1996; 122(4):219-22. PubMed ID: 8601574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventive effect of fermented brown rice and rice bran against colon carcinogenesis in male F344 rats.
    Katyama M; Yoshimi N; Yamada Y; Sakata K; Kuno T; Yoshida K; Qiao Z; Vihn PQ; Iwasaki T; Kobayashi H; Mori H
    Oncol Rep; 2002; 9(4):817-22. PubMed ID: 12066215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.
    Janakiram NB; Steele VE; Rao CV
    Cancer Prev Res (Phila); 2009 Jan; 2(1):52-9. PubMed ID: 19139018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemopreventive effects of PBI-Se, a selenium-containing analog of PBIT, on AOM-induced aberrant crypt foci in F344 rats.
    Janakiram NB; Mohammed A; Ravillah D; Choi CI; Zhang Y; Desai D; Amin S; Rao CV
    Oncol Rep; 2013 Aug; 30(2):952-60. PubMed ID: 23708609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats.
    Patlolla JM; Zhang Y; Li Q; Steele VE; Rao CV
    Int J Oncol; 2012 Jan; 40(1):170-5. PubMed ID: 21956158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of occurrence and advancement of beta-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib.
    Yamada Y; Yoshimi N; Hirose Y; Hara A; Shimizu M; Kuno T; Katayama M; Qiao Z; Mori H
    Jpn J Cancer Res; 2001 Jun; 92(6):617-23. PubMed ID: 11429049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 128.